1. Home
  2. blog

Blog

CorTec's Brain Interchange Accepted into FDA TAP; Third U.S. Patient Implanted

CorTec's Brain Interchange™ has been accepted into the FDA's Total Product Life Cycle Advisory Program and received Breakthrough Device Designation; the company reported a third patient implant in the NIH‑funded U.S. clinical study and nine months of stable device operation in the first U.S. participant.

25 Apr 2026

Report: Lucid-dreaming devices market to reach $201.8M by 2033; North America holds 40%

DataM Intelligence projects the lucid-dreaming devices market will grow from $113.1M in 2023 to $201.8M by 2033, with North America holding a 40% share. The report highlights REM-detection and EEG wearables, recent product updates from iWinks and Dreem, and gaps in clinical validation.

25 Apr 2026

Secondary head-to-head comparison: LIFU vs rTMS for motor recovery after stroke

A PLOS One secondary analysis of a randomized trial (n=50) found similar short‑term Fugl–Meyer and Barthel gains after subacute stroke with LIFU or rTMS, while LIFU produced larger change‑from‑baseline motor improvements and increased prefrontal fALFF on fNIRS.

25 Apr 2026

Review details mechanisms, clinical uses and limits of tACS across neuropsychiatric disorders

A review led by Prof. Hongxing Wang (Chinese Medical Journal, 5 Apr 2026) summarizes proposed mechanisms and reported clinical uses of tACS across depression, Alzheimer's, schizophrenia and stroke, and calls for larger randomized trials and closed-loop protocols.

23 Apr 2026

A “muddy intervention”: taVNS yields mixed outcomes for people with Long COVID

People with Long COVID are trying ear-based vagus nerve stimulation at home with mixed outcomes. Small trials, a 2024 survey and ongoing studies show both benefit for some users and reports of crashes and adverse effects; experts advise caution and physician oversight.

23 Apr 2026

Nature Reviews Bioengineering publishes framework for digital biomarkers in neurodegenerative disease

A Stanford-led review published 23 April 2026 in Nature Reviews Bioengineering presents a three‑pillar framework for digital biomarkers in neurodegenerative disease, highlights mature motor measures (like gait via IMUs) and lists gaps: small studies, interoperability, equity and cost-effectiveness.

23 Apr 2026
← 1 2 3 4 5 6 7 8 9 10 ... 16 17

Search

About Us

Stay updated with the latest events and innovations from BrainPatch.ai by following our news and updates!

Categories

Archives